Arcitumomab - CISMeF

Preferred Label : Arcitumomab;

NCIt synonyms : IMMU-4; Immunoglobulin G 1 (mouse monoclonal IMMU-4 Fab' fragment gamma-chain anti-human antigen CEA), disulfide with mouse Monoclonal IMMU-4 Light Chain;

NCIt definition : A murine IgG monoclonal Fab' fragment antibody directed against carcinoembryonic antigen (CEA), a protein that is overexpressed by many tumor cell types. For tumors that overexpress CEA, technetium-99m labeled arcitumomab may be used as an adjunct diagnostic imaging tool to obtain prognostic information following resection and to monitor for recurrent disease. (NCI04);

UNII : 79T6JRG308;

CAS number : 154361-48-5;

Drug name : CEA-Scan;

NCI Metathesaurus CUI : CL938206;

Details

Origin ID

C1494;

UMLS CUI

C4317011;

Automatic exact mappings (from CISMeF team)
- IMMU-4 monoclonal antibody [MeSH concept]
- arcitumomab [MeSH concept]
Currated CISMeF NLP mapping
- Arcitumomab (substance) [SNOMED CT concept]
- arcitumomab [MeSH Supplementary Concept]
False UMLS correspondences (reviewed by CISMeF team)
- technetium Tc-99m arcitumomab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Arcitumomab (substance) [SNOMED CT concept]
- arcitumomab [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients